Suppr超能文献

在普通人群中,为何接受治疗的高血压患者的心血管死亡率高于同龄人群。

Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population.

作者信息

Benetos Athanase, Thomas Frédérique, Bean Kathryn E, Guize Louis

机构信息

Centre d'Investigations Prèventives et Cliniques (IPC), Paris, France.

出版信息

J Hypertens. 2003 Sep;21(9):1635-40. doi: 10.1097/00004872-200309000-00011.

Abstract

OBJECTIVE

The aim of the present study was to assess whether increased cardiovascular mortality in treated hypertensives could be explained by high blood pressure levels, or by the presence of associated risk factors and/or associated diseases.

DESIGN

The study sample consisted of 8893 treated hypertensive men and women from the Investigations Préventives et Cliniques cohort, and 25880 gender-matched and age-matched untreated subjects from the same cohort. Vital status was obtained for an 8-12 year period.

RESULTS

Treated hypertensive subjects had higher systolic blood pressure (SBP) (+ 15 mmHg) and higher diastolic blood pressure (+ 9 mmHg), and a higher prevalence of associated risk factors and diseases. Treated hypertensives compared with untreated subjects presented a two-fold increase in the risk ratio (RR) for cardiovascular mortality [RR, 1.96; 95% confidence interval (CI), 1.74-2.22] and coronary mortality (RR, 1.99; 95% CI, 1.63-2.44). Adjustment for unmodifiable risk factors decreased the excess cardiovascular risk observed in treated subjects only slightly: RR, 1.77; 95% CI, 1.56-2.00 for cardiovascular mortality; and RR, 1.76; 95% CI, 1.44-2.16 for coronary mortality. After additional adjustment for modifiable associated risk factors, the increased mortality in treated subjects persisted: RR, 1.52; 95% CI, 1.33-1.74 for cardiovascular mortality; and RR, 1.49; 95% CI, 1.19-1.86 for coronary mortality. Only after additional adjustment for SBP were cardiovascular mortality and coronary mortality similar in the two groups of subjects: RR, 1.06; 95% CI, 0.92-1.23; and RR, 1.06; 95% CI, 0.85-1.35, respectively.

CONCLUSIONS

The increased cardiovascular mortality in treated hypertensive subjects as compared with untreated subjects is mainly due to high SBP levels under treatment. This result suggests that the excess risk found in treated hypertensives may be drastically reduced if SBP were brought under control.

摘要

目的

本研究旨在评估接受治疗的高血压患者心血管死亡率增加是由高血压水平升高所致,还是由相关危险因素和/或相关疾病的存在所致。

设计

研究样本包括来自预防性和临床研究队列的8893例接受治疗的高血压男性和女性,以及来自同一队列的25880例性别和年龄匹配的未接受治疗的受试者。随访8至12年以获取生命状态信息。

结果

接受治疗的高血压受试者收缩压(SBP)较高(+15 mmHg),舒张压较高(+9 mmHg),且相关危险因素和疾病的患病率较高。与未接受治疗的受试者相比,接受治疗的高血压患者心血管死亡率的风险比(RR)增加了两倍[RR,1.96;95%置信区间(CI),1.74 - 2.22],冠心病死亡率的风险比(RR,1.99;95%CI,1.63 - 2.44)。对不可改变的危险因素进行调整后,仅略微降低了在接受治疗的受试者中观察到的心血管额外风险:心血管死亡率的RR为1.77;95%CI,1.56 - 2.00;冠心病死亡率的RR为1.76;95%CI,1.44 - 2.16。在对可改变的相关危险因素进行额外调整后,接受治疗的受试者死亡率仍持续增加:心血管死亡率的RR为1.52;95%CI,1.33 - 1.74;冠心病死亡率的RR为1.49;95%CI,1.19 - 1.86。仅在对SBP进行额外调整后,两组受试者的心血管死亡率和冠心病死亡率才相似:RR分别为1.06;95%CI,0.92 - 1.23和RR,1.06;95%CI,0.85 - 1.35。

结论

与未接受治疗的受试者相比,接受治疗的高血压患者心血管死亡率增加主要是由于治疗期间的高SBP水平。这一结果表明,如果SBP得到控制,在接受治疗的高血压患者中发现的额外风险可能会大幅降低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验